Position in NBIX
as of Jun 30, 2026
· filed Aug 27, 2026
Position Value
$9,215,766
+$3,282,856 QoQ
Shares Held
54,680
+21.4% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#166
of 772 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 4%
Shared 2%
None 95%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $93,224,797 across 28 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
487,990 | $35,066,961 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
54,680 | $9,215,766 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
342,271 | $8,423,288 | |
| 4 | VTRS |
Viatris Inc
|
471,938 | $7,494,374 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
13,429 | $7,276,234 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
209,792 | $3,039,885 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
150,698 | $2,608,582 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
71,870 | $2,601,694 |
All Filings in NBIX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,215,766 | 54,680 | Shares | Other | 2026-08-27 | |
| 2026-03-31 | $5,932,910 | 45,035 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $759,783 | 5,357 | Shares | Sole | 2026-03-09 | |
| 2025-09-30 | $562,221 | 4,005 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $612,235 | 4,871 | Shares | Defined | 2025-09-26 | |
| 2025-03-31 | $464,519 | 4,200 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,082,034 | 7,927 | Shares | Other | 2025-02-10 | |
| 2024-09-30 | $556,858 | 4,833 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $610,704 | 4,436 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $526,716 | 3,819 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $419,260 | 3,182 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $355,387 | 3,159 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $287,520 | 3,049 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $525,736 | 5,194 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||